Abcam (LSE:ABC) Other Long-Term Liabilities : £-0.0 Mil (As of Jun. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Abcam Other Long-Term Liabilities?

Abcam's other long-term liabilities for the quarter that ended in Jun. 2023 was £-0.0 Mil.

Abcam's quarterly other long-term liabilities declined from Jun. 2022 (£0.0 Mil) to Dec. 2022 (£-0.0 Mil) and declined from Dec. 2022 (£-0.0 Mil) to Jun. 2023 (£-0.0 Mil).

Abcam's annual other long-term liabilities declined from Jun. 2019 (£0.1 Mil) to Jun. 2020 (£-0.0 Mil) and declined from Jun. 2020 (£-0.0 Mil) to Dec. 2022 (£-0.0 Mil).

Abcam Other Long-Term Liabilities Historical Data

The historical data trend for Abcam's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abcam Other Long-Term Liabilities Chart

Abcam Annual Data

Trend

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Dec22

Other Long-Term Liabilities

Get a 7-Day Free Trial

Abcam Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Jun22	Dec22	Jun23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Abcam Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Abcam Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Abcam's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Abcam (LSE:ABC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abcam PLC (LSE:ABC) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Discovery Drive, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AX

Website

https://www.abcam.com

Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.

Abcam (LSE:ABC) Headlines

No Headlines